Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-45
SponsorSecond Xiangya Hospital of Central South University

About this trial

The goal of this observational study is to learn whether adults with hidradenitis suppurativa (HS) have changes in resting brain activity and how these changes are related to disease severity, pain, sleep, mood, and quality of life. The study will also examine whether brain activity changes after patients receive biologic or small-molecule treatment as part of their regular medical care.

The main questions it aims to answer are:

* Are resting brain activity patterns different between people with HS and healthy participants? * Are these brain activity patterns related to HS severity, pain, sleep problems, anxiety, depression, and quality of life? * Do brain activity patterns change after 3 months of routine treatment, and are these changes related to improvement in HS symptoms? Researchers will compare participants with HS with healthy participants of similar age and sex. A subgroup of participants with HS who receive biologic or small-molecule treatment as part of routine clinical care will also be assessed before and after treatment.

Participants may:

* Complete assessments of HS severity, pain, sleep, mood, and quality of life * Undergo resting-state functional magnetic resonance imaging * Undergo skin ultrasound and routine laboratory testing * Allow photographs of affected skin areas to be taken * Return for follow-up assessments for up to 3 months

Eligibility criteria

Qualifiers

Aged 18 to 45 years.

Diagnosed with hidradenitis suppurativa according to established clinical diagnostic criteria.

Able and willing to comply with the study procedures and follow-up assessments.

Able to provide written informed consent and willing to permit photography of affected skin areas.

Disqualifiers

Participation in another investigational drug study within 1 month before enrollment.

Alcohol or drug abuse or dependence within the previous 3 months.

Current use of medications that may lower the seizure threshold or current use of antidepressant medication.

Previous or current treatment with electroconvulsive therapy, vagus nerve stimulation, or transcranial magnetic stimulation.

Trial design

Treatments tested in this trial

  • Routine Biologic Therapy for Hidradenitis Suppurativa

Treatment groups

80 Participants
are divided into 3 treatment groups